Favourable outcome of progressive multifocal leukoencephalopathy with mefloquine treatment in combination with antiretroviral therapy in an HIV-infected patient

International Journal of STD and AIDS

Volumn 23, Issue 8, 2012, Pages 603-605

  Adachi, E ^a   Koibuchi, T ^a   Imai, K ^a   Kikuchi, T ^a   Koga, M ^a   Nakamura, H ^a   Miura, T ^a   Iwamoto, A ^a   Fujii, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

AIDS; HIV; IRIS; Mefloquine; PML; Progressive multifocal leukoencephalopathy

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; MEFLOQUINE; PREDNISOLONE; RISPERIDONE; VIRUS DNA;

ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; APHASIA; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CONTRAST ENHANCEMENT; DYSARTHRIA; DYSPHAGIA; FACIAL NERVE PARALYSIS; HEMIPARESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JOHN CUNNINGHAM VIRUS; MALE; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SENSORY DYSFUNCTION; SLURRED SPEECH; VIRUS; WHITE MATTER LESION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; BRAIN; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; MEFLOQUINE; NEUROIMAGING;

EID: 84865810697     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2012.011305     Document Type: Article

References (8)

1. Cettomai D, McArthur JC. Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch Neurol 2009;66:255-8
2. Brickelmaier M, Lugovskoy A, Kartikeyan R, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 2009;53:1840-9
3. Berenguer J, Miralles P, Arrizabalaga J, et al. Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin Infect Dis 2003;36:1047-52
4. Gofton TE, Al-Khotani A, O'Farrell B, Ang LC, McLachlan RS. Mefloquine in the treatment of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry 2011;82:452-5
5. Kishida S, Tanaka K. Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant. Intern Med 2010;49:2509-13
6. Marzocchetti A, Tompkins T, Clifford DB, Gandhi RT, Kesari S, Berger JR. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 2009;73:1551-8
7. Tan K, Roda R, Ostrow L, McArthur J, Nath A. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 2009;72:1458-64
8. Du Pasquier RA, Koralnik IJ. Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? J Neurovirol 2003;9(Suppl. 1):25-31